Related references
Note: Only part of the references are listed.Trimethylamine-N-oxide is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation
Marco Luciani et al.
HEART (2023)
Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanisms and potential clinical implications
Monika Gawalko et al.
CARDIOVASCULAR RESEARCH (2022)
Gut Microbiota-Derived Metabolites and Cardiovascular Disease Risk: A Systematic Review of Prospective Cohort Studies
Raul Sanchez-Gimenez et al.
NUTRIENTS (2022)
A wearable electrochemical biosensor for the monitoring of metabolites and nutrients
Minqiang Wang et al.
NATURE BIOMEDICAL ENGINEERING (2022)
Trimethylamine-N-oxide (TMAO) is associated with cardiovascular mortality and vascular brain lesions in patients with atrial fibrillation
M Luciani et al.
EUROPEAN HEART JOURNAL (2021)
Does gut microbiota affect atrial rhythm? Causalities and speculations
Dominik Linz et al.
EUROPEAN HEART JOURNAL (2021)
Metagenomic data-mining reveals enrichment of trimethylamine-N-oxide synthesis in gut microbiome in atrial fibrillation patients
Kun Zuo et al.
BMC GENOMICS (2020)
Trimethylamine N-oxide as a risk marker for ischemic stroke in patients with atrial fibrillation
Zhaoguang Liang et al.
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2019)
Gut microbe-generated metabolite trimethylamine-N-oxide as cardiovascular risk biomarker: a systematic review and dose-response meta-analysis
Gabriele Giacomo Schiattarella et al.
EUROPEAN HEART JOURNAL (2017)